Management Team
Jeff Reich MD
CEO
Co-Founder
Jeffrey B Reich, MD has over 30 years of experience in the life sciences. For >20 years he was a portfolio manager overseeing healthcare related investments at Merlin BioMed and Cramer Rosenthal McGlynn. He was a founding board member of Neurologix, the first CNS directed gene therapy company. Prior to going to Wall St, Dr Reich was an Assistant Professor of Neurology and Neuroscience at the Weill Cornell Medical Center and an Attending Neurologist at the The New York Presbyterian Hospital. He has participated in numerous NIH and industry sponsored clinical drug trials. Dr. Reich received his BS from Binghamton University and MD from the Weill Cornell School of Medicine.
Annie Pasternak
Chief Operating Officer
Annie Pasternak is our Chief Operating Officer. Prior to Sparian, Annie was a consultant at ClearView Healthcare Partners advising biotech and pharmaceutical companies on pre-clinical, clinical, commercial, and pricing / market access strategies. Along with her industry experience, she brings in-depth expertise on the arylepoxamide series having worked and published on the foundational science for SBS-1000. Annie received an honors Bachelor's degree in neuroscience from Dartmouth College
Gus Northrop
Program Director
Gus Northrop, MBA is the Program Director at Sparian. Prior to joining Sparian, Gus worked at Merck & Co. on the KEYTRUDA marketing team and at BioMarin Pharmaceutical on the Pipeline Commercialization team. Gus also has 5 years of experience as a Consultant at Globe Life Sciences in London, advising biotech and pharmaceutical companies on various strategic issues. Gus holds a first-class BA in Medical Sciences from Oxford University and an MBA with Honors from Columbia University.
Alberto Bianchinotti, CPA
Chief Financial Officer
Alberto is Chief Financial Officer (CFO) of Sparian Biosciences. He has held a number of CFO roles with emerging companies, including, for over ten years at Nexus Life Science Partners, a crossover fund which invests in private and public biotech companies. Prior to that, he was controller at Merlin BioMed Investment Advisers, an investment manager focused on public life science companies. Alberto is a Certified Public Accountant with audit management, experience in executive and compliance roles, and received his BS in accounting from Binghamton University.
Scientific Co-Founders
Gavril Pasternak MD PhD
Company and Scientific
Co-Founder
Anne Burnett Tandy Chair of Neurology
Member and Laboratory Head
Molecular Pharmacology Program and Department of Neurology at MSK
Professor of Neurology, Neuroscience, Pharmacology and Psychiatry at Weill Cornell Medical College
Ying-Xian Pan MD PhD
Scientific Co-Founder
Professor
Dept of Anesthesiology
Rutgers, New Jersey Medical School
Susruta Majumdar PhD
Scientific Co-Founder
Associate Professor of Pharmacology and Pharmaceutical Sciences
Center for Clinical Pharmacology
St. Louis College of Pharmacy
Washington University School of Medicine St. Louis, MO